| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/14/2008 | WO2008017710A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | WO2008017649A1 Substituted azolin-2-yl-amino compounds |
| 02/14/2008 | WO2008017361A2 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 02/14/2008 | WO2008002571A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2008002570A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2008002569A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2008000950A3 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 02/14/2008 | WO2007139955A8 Triazole compounds that modulate hsp90 activity |
| 02/14/2008 | WO2007117381A3 2 -aminopyridine analogs as glucokinase activators |
| 02/14/2008 | US20080039630 Cyanine compounds and their application as quenching compounds |
| 02/14/2008 | US20080039629 Benzothniazole compositions and their use as ubiquition ligation inhibitors |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039511 Thiazole Compound and Use Thereof |
| 02/14/2008 | US20080039505 5-((((2R)-1-(4-((S)-1-hydroxyhexyl)phenyl)-4-methyl-5-oxopyrrolidin-2-yl)methoxy)methyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension |
| 02/14/2008 | US20080039502 e.g. N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 02/14/2008 | US20080039499 Chemical Compounds |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039440 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia |
| 02/14/2008 | US20080039377 Composition Comprising a Jnk Inhibitor and Cyclosporin |
| 02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
| 02/14/2008 | DE102006037478A1 2-(Heterocyclylbenzyl)-pyridazinonderivate 2- (Heterocyclylbenzyl) -pyridazinone derivatives |
| 02/14/2008 | CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | CA2660195A1 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 02/13/2008 | EP1887006A1 Polymorphic forms of rosiglitazone base |
| 02/13/2008 | EP1887003A1 3-[4-heterocyclyl -1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 02/13/2008 | EP1887002A1 Carboxamide compound and use thereof |
| 02/13/2008 | EP1886996A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1886693A1 Agent for regeneration and/or protection of nerves |
| 02/13/2008 | EP1885720A2 4-(thiazol-2-ylthioalkyl)-pyrazoles and their use as herbicides |
| 02/13/2008 | EP1885719A1 2,5- and 2,6-disubstituted benzazole derivatives useful as protein kinase inhibitors |
| 02/13/2008 | EP1885718A1 Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use |
| 02/13/2008 | EP1885717A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases |
| 02/13/2008 | EP1885716A1 Thiazole derivatives and use thereof |
| 02/13/2008 | EP1885362A2 Novel chemical compounds |
| 02/13/2008 | EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1335908B1 Peroxisome proliferator activated receptor alpha agonists |
| 02/13/2008 | EP1303272B1 Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease |
| 02/13/2008 | CN101124223A Pyrido-pyrimidine derivatives, preparation thereof, therapeutic use thereof |
| 02/13/2008 | CN101124222A Tetrahydroquinoline analogues as muscarinic agonists |
| 02/13/2008 | CN101124217A CGRP receptor antagonists |
| 02/13/2008 | CN101124208A Novel heteroaryl acetamide |
| 02/13/2008 | CN101124203A Chemical compounds |
| 02/13/2008 | CN101123962A 可诱导一氧化氮合成酶二聚化的抑制剂 Inducible nitric oxide synthase dimerization inhibitor |
| 02/13/2008 | CN101121712A Heterocycle-containing cinnamenylcoumarin derivatives and synthesizing method thereof |
| 02/13/2008 | CN100368415C 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 02/12/2008 | US7329765 Benzothiophene compounds having antiinfective activity |
| 02/12/2008 | US7329757 Chloroazinium compounds: 2-chloro-5-methyl-1-(3-trifluoromethyl-phenyl)-pyridinium chloride; intermediates for preparting iminoazine herbicides: N-cyclopropyl-5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridineimine |
| 02/12/2008 | US7329752 4-(tetrahydrofuran-2-carbonyl)piperazine-1-carboxylic acid 3-{(1S,3R,5R)-3-[(3-isopropyl-2-oxo-2,3-dihydro-benzoimidazole-1-carbonyl)amino]-8-aza-[3.2.1]oct-8-yl}propyl ester; disorder of reduced motility of the gastrointestinal tract |
| 02/12/2008 | US7329682 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative |
| 02/12/2008 | US7329680 Heterocycle substituted carboxylic acids |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 02/07/2008 | WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | WO2008016692A2 Chemical compounds |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008015517A2 Ep2 agonists |
| 02/07/2008 | WO2008015189A2 Fungicidal n-cycloalkyl-carboxamide derivatives |
| 02/07/2008 | WO2007140385A3 Thiazole compounds as cannabinoid receptor ligands and uses thereof |
| 02/07/2008 | WO2007121484A3 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 02/07/2008 | WO2007050050A3 Thiazolyl mglur5 antagonists and methods for their use |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/07/2008 | US20080033025 administering e.g. 5-[5-(1-trifluoromethyl-4-Chloro-phenyl)-furan-2-ylmethylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic acid as a bactericide to inhibit lethal factor (LF) protease activity of anthrax toxin |
| 02/07/2008 | US20080033023 Therapeutic compounds |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032995 Aldh-2 inhibitors in the treatment of drug addiction |
| 02/07/2008 | US20080032993 Substituted heterocyclic compounds |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase |
| 02/07/2008 | US20080032964 Process for the synthesis of azetidinone |
| 02/07/2008 | CA2659473A1 Chemical compounds |
| 02/07/2008 | CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/06/2008 | EP1884511A1 Aromatic ether compounds,preparation and usage thereof |
| 02/06/2008 | EP1884242A1 Pharmaceutical composition |
| 02/06/2008 | CN101119991A Salt of proline derivative, solvate thereof, and production method thereof |
| 02/06/2008 | CN101119970A Azadecalin glucocorticoid receptor modulators |
| 02/06/2008 | CN101119968A Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 02/06/2008 | CN100366618C Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/06/2008 | CN100366612C 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326788 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/05/2008 | US7326786 2-(Thiazol-2-ylamino)-5-[1-quinolin-6-yl-meth-(Z)-ylidene]-thiazol-4-one and derivatives; kinase inhibitors; antiproliferative agents; solid tumors |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326729 CXCR1 and CXCR2 chemokine antagonists |
| 02/05/2008 | US7326728 Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
| 02/05/2008 | US7326727 Furanthiazole derivatives as heparanase inhibitors |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326704 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
| 02/05/2008 | US7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |